TELA Bio to Participate in Canaccord Genuity’s 41st Annual Growth Conference

Rhea-AI Summary

MALVERN, Pa., Aug. 03, 2021 – TELA Bio, Inc. (NASDAQ: TELA) has announced its participation in Canaccord Genuity’s 41st Annual Growth Conference. Management will present on August 12, 2021, at 2:00 PM EDT. The company specializes in innovative tissue reinforcement materials aimed at enhancing soft tissue reconstruction outcomes. TELA’s OviTex® and OviTex PRS products are designed to improve hernia repair and abdominal wall reconstruction processes while minimizing reliance on synthetic materials.

News Market Reaction – TELA

-3.26%

-3.26% Session move

In the trading session that priced this news, TELA declined 3.26%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MALVERN, Pa., Aug. 03, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the Company will participate in Canaccord Genuity’s 41^st Annual Growth Conference.

TELA Bio's management is scheduled to present at Canaccord Genuity’s 41^st Annual Growth Conference on Thursday, August 12, 2021 at 2:00 PM EDT. Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The Company is committed to providing patients with advanced, economically effective biologic material repair solutions to minimize long-term exposure to permanent synthetic materials and improve clinical outcomes. TELA Bio's OviTex® and OviTex PRS Reinforced Tissue Matrix products are purposefully designed to address the shortcomings of existing reinforcement materials in hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery. For more information, visit www.telabio.com.

Investor Contact
Greg Chodaczek
347-620-7010 
ir@telabio.com

FAQ

When is TELA Bio's presentation at Canaccord Genuity’s 41st Annual Growth Conference?

TELA Bio's presentation is scheduled for August 12, 2021, at 2:00 PM EDT.

What is the focus of TELA Bio's products?

TELA Bio focuses on innovative tissue reinforcement materials for soft tissue reconstruction.

Where can I watch TELA Bio's conference presentation?

The presentation can be accessed live and archived at ir.telabio.com.

What are TELA Bio's main products?

TELA's main products include OviTex® and OviTex PRS Reinforced Tissue Matrix.

What is TELA Bio's stock symbol?

The stock symbol for TELA Bio is TELA, traded on NASDAQ.